Coburn, Natalie
3 papers on CoChatORCID 0000-0002-5313-717X
Most cited papers
- Verified
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study
Sangro, B., Kudo, M., Erinjeri, J. P., Qin, S., Ren, Z., Chan, S. L., Arai, Y., Heo, J., Mai, A., Escobar, J., et al. (2025) · The Lancet
Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers
Cited by 333
- Verified
Symptom Burden in the First Year After Cancer Diagnosis: An Analysis of Patient-Reported Outcomes
Bubis, L. D., Davis, L., Mahar, A., Barbera, L., Li, Q., Moody, L., Karanicolas, P., Sutradhar, R., & Coburn, N. G. (2018) · Journal of Clinical Oncology
Cancer survivorship and carePalliative and Oncologic Care
Cited by 187
- Verified
Patient-reported symptoms following diagnosis in esophagus cancer patients treated with palliative intent
Davis, L. E., Gupta, V., Allen-Ayodabo, C., Zhao, H., Hallet, J., Mahar, A. L., Ringash, J., Doherty, M., Kidane, B., Darling, G., et al. (2020) · Diseases of the Esophagus
Palliative Care and End-of-Life IssuesEsophageal Cancer Research and Treatment
Cited by 14
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free